Ann Child Neurol Search

CLOSE


Ann Child Neurol > Volume 34(1); 2026 > Article
Eom: Autism Spectrum Disorder: From Screening to Early Diagnosis and Intervention

Abstract

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by deficits in social communication and the presence of restricted, repetitive behaviors. This mini-review provides an overview of the continuum from ASD screening to early diagnosis and intervention. With the global prevalence of ASD steadily increasing, early identification, particularly during critical periods of neuroplasticity, is essential for optimizing long-term outcomes. Screening tools such as the Modified Checklist for Autism in Toddlers facilitate early detection, while multidisciplinary diagnostic evaluations guided by standardized criteria, including the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, confirm the diagnosis and assess comorbid conditions. Evidence-based early interventions that integrate behavioral, developmental, and educational strategies aim to address core symptoms, enhance adaptive functioning, and foster independence. Approaches such as applied behavior analysis, developmental relationship-based therapies, and naturalistic developmental behavioral interventions have demonstrated strong efficacy, especially when introduced during toddlerhood. Family participation is central to the success of these interventions, as it supports skill generalization and reduces caregiver stress. Despite persistent challenges related to screening accuracy and the heterogeneity of ASD, particularly in females and individuals with subtle presentations, ongoing advances in personalized interventions and diagnostic technologies underscore the importance of early, comprehensive care. This review emphasizes the critical role of timely screening, accurate diagnosis, and individualized intervention in improving the quality of life for children with ASD and their families.

Introduction

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by marked impairments in social communication and interaction, along with restricted and repetitive behaviors and interests. The understanding and diagnostic framework of ASD have evolved substantially since the condition was first described by Leo Kanner in 1943 and Hans Asperger in 1944 [1-3]. Over the past several decades, epidemiological research has documented a striking rise in ASD prevalence, with current estimates suggesting that approximately one in 36 children in the United States is affected. This increase, from 0.04% in the 1970s to between 1% and 2.8% today, depending on the region, likely reflects a combination of factors, including greater public awareness, modifications to diagnostic criteria, and improvements in screening practices [4-6].
ASD is now recognized as a spectrum disorder encompassing a broad range of manifestations and severities, consolidated under a single diagnostic category in both the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and International Classification of Diseases, 11th Revision (ICD-11) [1,7]. Early developmental indicators, such as delayed language acquisition, diminished eye contact, and restricted interests, may emerge before the age of two and are often first identified by parents or caregivers [8,9]. However, despite increasing awareness, the average age of formal diagnosis remains approximately three to four years, resulting in delays in access to effective interventions [4,9]. Early identification is vital, as mounting evidence shows that timely intervention can significantly shape developmental trajectories and long-term outcomes, improving adaptive functioning, social communication, and overall quality of life.
Genetic studies have underscored the strong heritability of ASD, implicating more than 100 genes and complex interactions with environmental risk factors. Neurobiological research has revealed distinctive patterns of brain development and connectivity among individuals with ASD, some originating prenatally and resulting in functional and structural differences across multiple brain regions [3,8,10].
Despite these advances, no curative treatment currently exists for ASD. Consequently, the focus remains on early detection and individualized intervention strategies that integrate behavioral therapy, speech and occupational therapy, and educational support tailored to each child’s unique profile. Given the lifelong and heterogeneous nature of the disorder, comprehensive, multidisciplinary support from healthcare providers, educators, therapists, and families is essential for optimizing outcomes and promoting social inclusion across the lifespan [11-14].
This review provides an updated overview of the process from ASD screening to early diagnosis and intervention, emphasizing the pivotal role each stage plays in improving the lives of children and families affected by ASD.

Screening for ASD

Early detection of ASD is essential, as it enables timely intervention that can markedly improve developmental outcomes for at-risk children. Screening aims to identify those who may require further evaluation and intervention, even before the full expression of the disorder. The American Academy of Pediatrics recommends standardized ASD screening at both 18 and 24 months of age, recognizing this developmental period as particularly critical for identifying children at risk [9,15,16].
The most widely used screening tool for these age groups is the Modified Checklist for Autism in Toddlers (M-CHAT), a parent-completed questionnaire designed to detect core ASD symptoms such as social communication deficits and repetitive behaviors. M-CHAT is both practical and effective in primary care settings, increasing the sensitivity of physician-led detection from only 24% without standardized tools to more than 90% when implemented. These findings highlight the limitations of relying solely on brief, unstructured clinical observations and emphasize the importance of educating parents about early warning signs [16,17].
Red flags that should prompt further evaluation include limited eye contact, social withdrawal, delayed language development, repetitive or echolalic speech, atypical responses to questions, rigid adherence to routines, and repetitive movements such as hand-flapping or spinning. Additional early indicators include excessive sensitivity to sensory input, lack of response to name by 12 months, failure to point to indicate interest by 14 months, and absence of pretend play by 18 months. Parental recognition of these core symptoms is critical, as early parental concern has consistently been shown to predict timely ASD identification [9,16,17].
In addition to M-CHAT, several other screening instruments are available. The Communication and Symbolic Behavior Scales Developmental Profile (CSBS DP) evaluates communication and play skills in children aged 6 to 24 months and is particularly valuable for siblings of children with ASD, who are at higher risk. The Korean Version of the Social Communication Questionnaire (K-SCQ) has been adapted for older children in Korea, though its sensitivity for detecting core social symptoms in preschool-aged populations remains under investigation. Recent studies indicate high sensitivity of the K-SCQ, though the evidence base is still limited [18,19]. General developmental screening tests, such as the Korean Developmental Screening Test (K-DST), can identify language and cognitive delays but often lack the sensitivity to detect the specific social communication deficits characteristic of ASD. Therefore, ASD-specific screening tools remain indispensable for early detection programs [6,16,20].
For children under 18 months, tools like the CSBS DP may offer some guidance, although none are definitive at this age. Between 18 and 30 months, M-CHAT and its revised versions (M-CHAT-R/F) are the most extensively validated instruments, with structured follow-up questions improving accuracy and reducing false positives. Children scoring eight or more points on the M-CHAT-R/F should be referred immediately for comprehensive assessment, while those with intermediate scores benefit from follow-up interviews to clarify results. Notably, even children who screen positive but do not meet full diagnostic criteria for ASD at this stage frequently present with other developmental issues and can still gain substantial benefit from early intervention [6,8,16].
For children older than 30 months, no universally validated screening tool is currently recommended for routine pediatric use. The Social Communication Questionnaire (SCQ) has been evaluated across a broad age range but may lack specificity for ASD, particularly when distinguishing it from other neurodevelopmental disorders such as attention-deficit/hyperactivity disorder (ADHD). Therefore, ongoing developmental surveillance, repeated screening, and active parental consultation remain essential in this age group rather than reliance on a single screening episode [4,6,9].
Several challenges persist in ASD screening. Children with milder symptoms or higher cognitive abilities may not be identified until later, often when social expectations increase in formal educational settings. Girls are particularly vulnerable to delayed recognition due to subtler behavioral presentations. Additionally, language and cultural factors can influence both the performance and acceptability of screening instruments. Thus, culturally adapted and locally validated tools, along with enhanced cultural competency among screeners, are vital for effective early identification [4,6,9,16,20].
In Korea, as in many other countries, the expansion of routine screening programs and increasing familiarity with standardized tools among pediatricians have led to earlier and more reliable identification of children at risk for ASD. Strong public health infrastructure, including clear referral pathways from primary care to specialized diagnostic and intervention services, is essential to ensure that children who screen positive receive timely follow-up and support [6,9,16,20].
In summary, ASD screening is a complex yet critical process that depends on validated, age- and culturally-appropriate tools, active parental participation, and robust healthcare systems (Table 1, Fig. 1). Although several challenges persist, systematic early screening remains one of the most effective strategies for enabling timely intervention and optimizing developmental outcomes for children with ASD.

Early Diagnostic Evaluation

Early diagnostic evaluation of ASD is essential, as it forms the foundation for timely intervention and increases the likelihood of improved developmental outcomes. Accurate diagnosis requires a multidisciplinary approach that accounts for the diverse presentation of ASD and the frequent presence of co-occurring neurodevelopmental or medical conditions [1-3,8,9].
The first phase typically begins with systematic observation and documentation of the child’s symptoms by caregivers and professionals. Parental input is invaluable, as parents often provide the earliest insights into social communication difficulties, language delays, and unusual behaviors. Clinicians encourage caregivers to record behavioral patterns, reactions to sensory stimuli, and any observed ‘red flag’ symptoms, such as a lack of eye contact, absence of pretend play, repetitive movements, echolalia, or atypical sensory responses. These observations, particularly when supported by developmental screening tools, help determine whether a comprehensive diagnostic assessment is warranted [6,9,16].
When ASD is suspected, the child proceeds to a detailed diagnostic evaluation conducted by a multidisciplinary team. This team typically includes pediatricians, child psychiatrists, clinical psychologists, speech-language pathologists, and occupational therapists. Their collaboration ensures that behavioral, communicative, social, cognitive, and adaptive domains are assessed holistically. The goal is to determine whether the child’s symptoms are most consistent with ASD and to distinguish them from other developmental, medical, or psychiatric conditions [1,3,8,9].
The DSM-5 serves as the standard diagnostic framework. It defines ASD based on persistent deficits in social communication and interaction across multiple contexts, as well as restricted, repetitive patterns of behavior, interests, or activities. Diagnosis requires all three social communication criteria—deficits in socioemotional reciprocity, nonverbal communication, and relationship development—along with at least two symptoms in the domain of restricted and repetitive behaviors, such as motor stereotypies, insistence on sameness, intense fixations, or abnormal sensory responses. The DSM-5 also grades symptom severity across three levels to reflect the degree of support required in daily life [1,3,8,9,12].
A variety of standardized assessment tools assist in the diagnostic process. Core instruments include the Autism Diagnostic Observation Schedule (ADOS) and the Autism Diagnostic Interview-Revised (ADI-R), both internationally recognized for their validity and reliability. The ADOS uses structured social scenarios to directly observe communication, social interaction, and play behaviors, while the ADI-R is a comprehensive caregiver interview capturing developmental history and behavioral profiles. Together, these tools provide complementary perspectives that substantially improve diagnostic accuracy, though they require specialized training and can be time-intensive, particularly the ADI-R [2,3,12,13,21].
Additional screening and diagnostic instruments, such as the Childhood Autism Rating Scale (CARS), the SCQ, and locally adapted checklists like the Korean Childhood Autism Rating Scale (K-CARS), help clinicians refine diagnostic impressions, especially in community or primary care settings. Some screening tools, such as the M-CHAT, may also inform diagnostic evaluation, particularly when positive results prompt further assessment [6,9,12,16,20].
A critical component of the evaluation is the identification of co-occurring conditions. Children with ASD frequently exhibit intellectual disability, language impairment, ADHD, epilepsy, sleep disturbances, or anxiety and mood disorders. Proper recognition of these comorbidities not only clarifies the overall clinical picture but also guides individualized intervention planning. A detailed medical history and neurological examination are essential. Genetic testing for Fragile X syndrome is recommended for all children suspected of having ASD, while testing for Rett syndrome should be considered, particularly in girls. Additional genetic evaluation, neuroimaging (magnetic resonance imaging), or electroencephalography may be warranted when medical ‘red flags’ or developmental regression are present [8-10,22,23].
The diagnostic process also emphasizes the evaluation of adaptive functioning, daily living skills, and family context. Instruments such as the Vineland Adaptive Behavior Scales and the Social Maturity Scale provide insights into functional abilities, while cognitive and language assessments help delineate the child’s strengths and areas for support. Active caregiver involvement—from sharing developmental histories to participating in feedback discussions—is critical for ensuring that diagnostic findings translate into an actionable, family-centered intervention plan [14,20,23,24].
It is also important to recognize that ASD presentations vary across the lifespan and between genders. Girls and individuals with higher cognitive abilities are at particular risk for delayed or missed diagnosis due to subtler social difficulties or compensatory behaviors. Therefore, repeated assessments and continued clinical vigilance are recommended, particularly during developmental transitions such as school entry or adolescence, when new challenges may emerge [2,4,6,8,9].
In summary, early diagnostic evaluation of ASD is a multidisciplinary, stepwise process that integrates clinical observation, caregiver reports, standardized tools, and team-based expertise (Table 2, Fig. 1). Its objective is not only to confirm the presence of ASD but also to identify co-occurring conditions, assess functional impact, and empower families through a personalized, family-centered intervention plan designed to promote optimal developmental outcomes.

Early Intervention Strategies

Early intervention for individuals with ASD is universally recognized as a critical determinant of improved developmental outcomes and functional independence. The goal of effective treatment is to minimize core deficits in social communication and interaction, reduce restrictive and repetitive behaviors, and address associated behavioral challenges that impair daily functioning. A tailored and intensive approach that considers each individual’s developmental profile and specific needs is essential. Early identification and prompt initiation of therapy capitalize on the brain’s heightened neuroplasticity during infancy and toddlerhood, maximizing the benefits of intervention. Importantly, intervention is not a short-term undertaking but a lifelong process that requires ongoing adaptation as children transition through developmental stages—from infancy to adolescence and adulthood [8,9,12,13,15,25].
Given the heterogeneity of ASD, no single intervention is universally effective. Treatments must be individualized and structured according to the child’s age, developmental level, language abilities, strengths, and challenges. For toddlers newly diagnosed with ASD, interventions commonly integrate behavioral and developmental strategies delivered in naturalistic or educational settings, including specialized preschool programs. As children mature, the focus expands to include adaptive functioning and daily living skills alongside continued behavioral and developmental support. Family education and participation remain indispensable throughout, as the rigidity and resistance to change characteristic of ASD can be highly stressful for families and affect their quality of life. Providing families with education about the nature and etiology of ASD and promoting acceptance rather than attempts to suppress behaviors fosters a healthier environment. Equal emphasis should be placed on holistic well-being—including adequate sleep, balanced nutrition, physical activity, and psychological health—while ensuring caregivers receive appropriate emotional support [11-15,25].
Managing co-occurring medical and psychiatric conditions is also essential. Many individuals with ASD experience associated disorders such as ADHD, anxiety, mood disorders, epilepsy, or intellectual disability. These comorbidities can complicate treatment and negatively influence quality of life. Comprehensive evaluation and targeted management of such conditions are therefore integral to an effective intervention plan [9,12,23].
Among evidence-based interventions, applied behavior analysis (ABA) is one of the most established. ABA-based programs, particularly early intensive behavioral intervention (EIBI), apply behavioral principles such as reinforcement and shaping to teach adaptive skills and reduce maladaptive behaviors. EIBI typically consists of one-on-one therapy for 20 to 40 hours per week over several years, with active parental participation to ensure generalization across settings. While early studies demonstrated significant developmental gains, recent meta-analyses have highlighted limitations in high-quality randomized controlled trials, underscoring the need for continued refinement and individualization of ABA approaches [12-15,25,26].
Developmental and relationship-based interventions, including joint attention symbolic play engagement regulation (JASPER) and the Preschool Autism Communication Trial (PACT), emphasize enhancing social communication through spontaneous, reciprocal interactions between children and caregivers. These approaches foster joint attention, imitation, and affective engagement through play-based, child-directed activities. Notably, they have demonstrated meaningful improvements in social communication, particularly in very young children [12,13].
Naturalistic developmental behavioral interventions (NDBIs), such as the Early Start Denver Model (ESDM), integrate behavioral principles within natural contexts, blending developmental theory with ABA. ESDM targets toddlers using comprehensive strategies to improve language, social, and adaptive skills through play-based sessions conducted at home or in community environments. Clinical trials have shown positive effects on intelligence quotient (IQ), language, and social functioning among children receiving sustained ESDM therapy. Although NDBIs show strong efficacy for enhancing social communication skills, their effects on repetitive or restricted behaviors remain relatively limited [12-15,26,27].
Educational interventions for children with ASD often combine structured teaching, visual supports, and individualized curricula. Programs such as Treatment and Education of Autistic and Related Communication Handicapped Children (TEACCH) and Learning Experiences and Alternative Programs for Preschoolers and Their Parents (LEAP) promote learning in inclusive classrooms alongside typically developing peers, balancing specialized support with opportunities for mainstream social interaction. These programs emphasize predictability, organization, and skill generalization, benefiting children across a wide spectrum of cognitive and adaptive abilities [23,25,28].
Focused interventions aim to improve specific skills or behaviors over shorter durations, complementing broader treatment frameworks. Parent-implemented interventions empower caregivers to actively participate in therapy, improving effectiveness and ensuring consistency across environments. Peer-mediated interventions involve typically developing peers to model and reinforce social behaviors. Additional focused methods include pivotal response training (PRT), which enhances motivation and responsiveness, and self-management strategies, which help children monitor and regulate their own behaviors. Technology-assisted interventions, such as communication applications and video modeling, also provide valuable tools for promoting communication and skill acquisition [12,13,25,28].
Focused interventions aim to improve specific skills or behaviors over shorter durations, complementing broader treatment frameworks. Parent-implemented interventions empower caregivers to actively participate in therapy, improving effectiveness and ensuring consistency across environments. Peer-mediated interventions involve typically developing peers to model and reinforce social behaviors. Additional focused methods include PRT, which enhances motivation and responsiveness, and self-management strategies, which help children monitor and regulate their own behaviors. Technology-assisted interventions, such as communication applications and video modeling, also provide valuable tools for promoting communication and skill acquisition [12,13,25,28].
Addressing challenging behaviors requires a comprehensive and empathetic approach. Positive behavior support, rooted in ABA principles, focuses on modifying environmental factors and teaching alternative adaptive behaviors rather than relying on punitive measures. Functional behavior analysis helps identify the triggers of problem behaviors, guiding individualized interventions that improve the well-being of both individuals with ASD and their caregivers [9,12-14,17].
Ultimately, ongoing family education is the cornerstone of successful intervention. Families require sustained guidance, training, and emotional support to maintain engagement and prevent burnout. Parents serve as essential collaborators in therapy, ensuring that acquired skills are consistently applied in daily routines and natural social contexts [9,11,13,14].
In summary, early intervention strategies for ASD highlight the importance of individualized, intensive, and multidisciplinary approaches initiated promptly after diagnosis or suspicion (Table 3, Fig. 1). These interventions aim to strengthen social communication, reduce maladaptive behaviors, address co-occurring conditions, and foster lifelong independence and well-being. Families and caregivers play an indispensable role throughout this process and require comprehensive support to optimize outcomes for individuals with ASD.

Conclusion

Early intervention for individuals with ASD is pivotal in improving long-term developmental outcomes and promoting functional independence. Given the wide heterogeneity in ASD presentations, effective intervention strategies must be individualized to address each child’s distinct needs, strengths, and challenges. By targeting core deficits in social communication and behavior while managing co-occurring conditions, early intervention provides the foundation for meaningful developmental progress and sustained growth across the lifespan.
A major advantage of early intervention lies in its capacity to harness the brain’s neuroplasticity during the critical developmental periods of infancy and toddlerhood. Timely and intensive therapeutic engagement can yield significant improvements in language, social interaction, and adaptive functioning, ultimately enhancing overall quality of life. However, it is essential to recognize that intervention should not be regarded as a finite or short-term endeavor but rather as a continuous, adaptive process that evolves with the child’s developmental needs and life stages.
The success of early intervention also depends heavily on family involvement. Parents and caregivers play an indispensable role in reinforcing acquired skills within natural environments, ensuring consistency across settings, and providing emotional stability for the child. Comprehensive family education, psychosocial support, and stress management strategies are vital to sustaining engagement and preventing caregiver burnout.
Furthermore, effective management of co-occurring medical and psychiatric conditions is critical. Many children with ASD present with additional challenges such as ADHD, anxiety, epilepsy, or intellectual disability, which can complicate treatment and influence overall outcomes. A holistic, multidisciplinary framework that integrates behavioral, developmental, and medical management remains essential for addressing these complexities and optimizing care.
In conclusion, early intervention for ASD must be individualized, intensive, and holistic, involving multidisciplinary collaboration and sustained family engagement. By promoting developmental milestones, promoting adaptive functioning, and supporting families, we can maximize the potential for individuals with ASD to achieve fulfilling, independent lives. Early, comprehensive intervention represents the cornerstone of a positive and inclusive future.

Conflicts of interest

No potential conflict of interest relevant to this article was reported.

Author contribution

Conceptualization: THE. Methodology: THE. Visualization: THE. Writing- original draft: THE. Writing- review & editing: THE.

Fig. 1.
Screening, diagnostic, and intervention pathway for autism spectrum disorder (ASD). M-CHAT, Modified Checklist for Autism in Toddler; DSM-5, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; ADOS, Autism Diagnostic Observation Schedule; ADI-R, Autism Diagnostic Interview-Revised; ID, intellectual disability; ADHD, attention-deficit/hyperactivity disorder; ABA, applied behavioral analysis; ESDM, Early Start Denver Model; NDBI, naturalistic developmental behavioral interventions; TEACCH, Treatment and Education of Autistic and Related Communication Handicapped Children.
acn-2025-01067f1.jpg
Table 1.
Autism spectrum disorder screening tools
Target age (mo) Main feature
CSDS DP 6-24 Assesses early communication, social behavior, and symbolic play through observation
M-CHAT (R/F) 16-30 Brief parent-completed questionnaire with structured follow-up interview
SCQ (K-SCQ) 24 and above Parent-report questionnaire focusing on social communication behaviors
K-DST 4-71 Nationwide developmental screening covering multiple domains including communication and social interaction

CSBS DP, Communication and Symbolic Behavior Scales Developmental Profile; M-CHAT (R/F), Modified Checklist for Autism in Toddlers, Revised with Follow-up; SCQ (K-SCQ), Social Communication Questionnaire (Korean version); K-DST: Korean Developmental Screening Test.

Table 2.
Autism spectrum disorder diagnostic evaluation tools
Age range (yr) Assessment type Distinctive features
ADOS-2 ≥1 Semi-structured observation Gold-standard diagnostic tool; modular format based on language ability
ADI-R ≥2 Semi-structured caregiver interview Gold-standard diagnostic tool; comprehensive developmental history; time-intensive
K-CARS 3-21 Observation+caregiver interview Official Korean version; efficient tool for screening and severity rating
K-GARS-2 3-22 Interview+observation Korean-standardized second edition; normalized on Korean population

ADOS-2, Autism Diagnostic Observation Schedule, Second Edition; ADI-R, Autism Diagnostic Interview-Revised; K-CARS, Korean version of the Childhood Autism Rating Scale; K-GARS-2, Korean version of the Gilliam Autism Rating Scale, 2nd Edition.

Table 3.
Major evidence-based autism spectrum disorder early intervention approaches
Primary target group Core principle Typical setting and format
EIBI (ABA) Toddlers Intensive behavioral reinforcement One-on-one intensive sessions; parent involvement
ESDM (NDBI) 12-48 mo Naturalistic approach combining ABA and developmental strategies Home or center-based; play-based, structured activities
PACT/JASPER Toddlers to school-age children Interaction- and relationship-focused therapy Parent-child sessions; play-centered format
TEACCH/LEAP Preschool to school-age children Structured teaching with visual supports Inclusive classroom settings; educational environments

EIBI, early intensive behavioral intervention; ABA, applied behavior analysis; ESDM, Early Start Denver Model; NDBI, naturalistic developmental behavioral intervention; PACT, Preschool Autism Communication Trial; JASPER, joint attention symbolic play engagement regulation; TEACCH, Treatment and Education of Autistic and Related Communication Handicapped Children; LEAP, Learning Experiences and Alternative Programs for Preschoolers and Their Parents.

References

1. American Psychiatric Association. Neurodevelopmental disorders: DSM-5® selections. Arlington: American Psychiatric Publishing; 2015.

2. Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet 2018;392:508-20.
crossref pmid pmc
3. Lord C, Brugha TS, Charman T, Cusack J, Dumas G, Frazier T, et al. Autism spectrum disorder. Nat Rev Dis Primers 2020;6:5.
crossref pmid pmc pdf
4. Shaw KA, Bilder DA, McArthur D, Williams AR, Amoakohene E, Bakian AV, et al. Early identification of autism spectrum disorder among children aged 4 years: autism and developmental disabilities monitoring network, 11 sites, United States, 2020. MMWR Surveill Summ 2023;72:1-15.

5. Salari N, Rasoulpoor S, Rasoulpoor S, Shohaimi S, Jafarpour S, Abdoli N, et al. The global prevalence of autism spectrum disorder: a comprehensive systematic review and meta-analysis. Ital J Pediatr 2022;48:112.
crossref pmid pmc pdf
6. Lee N, Hong Y, Kim Y. Screening instruments for autism spectrum disorder: mini review. J Korean Neuropsychiatr Assoc 2019;58:192-201.
crossref pdf
7. Greaves-Lord K, Skuse D, Mandy W. Innovations of the ICD-11 in the field of autism spectrum disorder: a psychological approach. Clin Psychol Eur 2022;4:e10005.
crossref pmid pmc pdf
8. Zwaigenbaum L, Bauman ML, Choueiri R, Kasari C, Carter A, Granpeesheh D, et al. Early intervention for children with autism spectrum disorder under 3 years of age: recommendations for practice and research. Pediatrics 2015;136 Suppl 1:S60-81.
crossref pmid pdf
9. Hyman SL, Levy SE, Myers SM. Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics 2020;145:e20193447.
crossref pmid
10. Zwaigenbaum L, Young GS, Stone WL, Dobkins K, Ozonoff S, Brian J, et al. Early head growth in infants at risk of autism: a baby siblings research consortium study. J Am Acad Child Adolesc Psychiatry 2014;53:1053-62.
crossref pmid pmc
11. Frye RE. A personalized multidisciplinary approach to evaluating and treating autism spectrum disorder. J Pers Med 2022;12:464.
crossref pmid pmc
12. Rogers SJ, Vismara LA. Evidence-based comprehensive treatments for early autism. J Clin Child Adolesc Psychol 2008;37:8-38.
crossref pmid pmc
13. Hume K, Steinbrenner JR, Odom SL, Morin KL, Nowell SW, Tomaszewski B, et al. Evidence-based practices for children, youth, and young adults with autism: third generation review. J Autism Dev Disord 2021;51:4013-32.
crossref pmid pmc pdf
14. Eapen V, Karlov L, John JR, Beneytez C, Grimes PZ, Kang YQ, et al. Quality of life in parents of autistic children: a transcultural perspective. Front Psychol 2023;14:1022094.
crossref pmid pmc
15. Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics 2010;125:e17-23.
crossref pdf
16. Robins DL, Casagrande K, Barton M, Chen CM, Dumont-Mathieu T, Fein D. Validation of the modified checklist for Autism in toddlers, revised with follow-up (M-CHAT-R/F). Pediatrics 2014;133:37-45.
crossref pmid pmc
17. LaVigna GW, Willis TJ. The efficacy of positive behavioural support with the most challenging behaviour: the evidence and its implications. J Intellect Dev Disabil 2012;37:185-95.
crossref pmid
18. Kim JH, Sunwoo HJ, Park SB, Noh DH, Jung YK, Cho IH, et al. A validation study of the Korean version of social communication questionnaire. J Korean Acad Child Adolesc Psychiatry 2015;26:197-208.
crossref
19. Lee Y, Bong G, Song DY, Yoo H. Combination of two primary screening instruments (K-SCQ and K-SRS-2) and setting of new cutoff values to improve diagnostic accuracy of autism spectrum disorder in young children. Psychiatry Investig 2025;22:757-65.
crossref pmid pmc pdf
20. Jung HJ, Eun BR, Kim SW, Yoo HJ, Um SY, Kim JS. Development of standard protocols for diagnosis and treatment of neurodevelopmental disorders in infancy & childhood. Cheongju: Korea Center for Disease Control and Prevention; 2016 [cited 2025 Nov 27]. Available from: https://scienceon.kisti.re.kr/srch/selectPORSrchReport.do?cn=TRKO201600015679

21. Lord C, Rutter M, DiLavore PC, Risi S, Gotham K, Bishop SL, et al. Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) Manual. Torrance: Western Psychological Services; 2012.

22. Genovese A, Butler MG. Clinical assessment, genetics, and treatment approaches in autism spectrum disorder (ASD). Int J Mol Sci 2020;21:4726.
crossref pmid pmc
23. Sparrow SS, Cicchetti DV, Saulnier CA. Vineland Adaptive Behavior Scales, Third Edition (Vineland-3). San Antonio: PsychCorp.; 2016.

24. Mullen EM. Mullen scales of early learning: AGS edition. Circle Pines: American Guidance Service Inc.; 1995.

25. Steinbrenner JR, Hume K, Odom SL, Morin KL, Nowell SW, Tomaszewski B, et al. Evidence-based practices for children, youth, and young adults with autism. Chapel Hill: The University of North Carolina, Frank Porter Graham Child Development Institute, National Clearinghouse on Autism Evidence and Practice Review Team; 2020.

26. Sandbank M, Bottema-Beutel K, Crowley S, Cassidy M, Dunham K, Feldman JI, et al. Project AIM: autism intervention meta-analysis for studies of young children. Psychol Bull 2020;146:1-29.
crossref pmid
27. Sandbank M, Bottema-Beutel K, Crowley LaPoint S, Feldman JI, Barrett DJ, Caldwell N, et al. Autism intervention meta-analysis of early childhood studies (Project AIM): updated systematic review and secondary analysis. BMJ 2023;383:e076733.
crossref pmid pmc
28. Wong C, Odom SL, Hume KA, Cox AW, Fettig A, Kucharczyk S, et al. Evidence-based practices for children, youth, and young adults with autism spectrum disorder: a comprehensive review. J Autism Dev Disord 2015;45:1951-66.
crossref pmid pdf
TOOLS
Share :
Facebook Linked In Line it
METRICS Graph View
  • 0 Crossref
  •   Scopus 
  • 242 View
  • 3 Download
Related articles in Ann Child Neurol

Vitamin D and Autism Spectrum Disorder: An Intriguing Association2024 April;32(2)



ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
372, Hangang-daero, Yongsan-gu, Seoul 04323, Republic of Korea 703, Building A, Centreville Asterium Seoul
Tel: +82-2-2138-3303    Fax: +82-2-743-3455    E-mail: editor@annchildneurol.org                

Copyright © 2026 by Korean Child Neurology Society.

Developed in M2PI

Close layer
prev next